Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DM1001 Transdermal Patch in Healthy Chinese Participants
NCT07844954Phase 1Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Sep 2026
- Primary completion
- Dec 2027
01
Overview
Phase 1, randomised, double-blind trial of DM1001 (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Number of Participants With Treatment-Emergent Adverse Events, Serious Adverse Events, or Adverse Events Leading to Study Withdrawal, Maximum Observed Plasma Concentration and 15 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
DM1001
Beyond the preview
Go deeper on NCT07844954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07844954.